Unlock stock picks and a broker-level newsfeed that powers Wall Street.

IOB - Delayed Quote EUR

Redcare Pharmacy NV (0RJT.IL)

Compare
124.70
-3.05
(-2.39%)
At close: April 17 at 5:33:58 PM GMT+1
Loading Chart for 0RJT.IL
  • Previous Close 127.75
  • Open 126.70
  • Bid 118.50 x --
  • Ask 132.30 x --
  • Day's Range 124.30 - 126.70
  • 52 Week Range 95.75 - 171.20
  • Volume 1,122
  • Avg. Volume 9,167
  • Market Cap (intraday) 2.269B
  • Beta (5Y Monthly) 0.95
  • PE Ratio (TTM) --
  • EPS (TTM) -2.26
  • Earnings Date May 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Redcare Pharmacy NV owns and operates online pharmacies in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.

www.redcare-pharmacy.com

1,638

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0RJT.IL

View More

Performance Overview: 0RJT.IL

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

0RJT.IL
9.01%
DAX P (^GDAXI)
6.51%

1-Year Return

0RJT.IL
8.31%
DAX P (^GDAXI)
19.34%

3-Year Return

0RJT.IL
57.45%
DAX P (^GDAXI)
49.72%

5-Year Return

0RJT.IL
82.98%
DAX P (^GDAXI)
99.57%

Compare To: 0RJT.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0RJT.IL

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    2.47B

  • Enterprise Value

    2.54B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.08

  • Price/Book (mrq)

    5.31

  • Enterprise Value/Revenue

    1.07

  • Enterprise Value/EBITDA

    90.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.18%

  • Return on Assets (ttm)

    -0.77%

  • Return on Equity (ttm)

    -8.91%

  • Revenue (ttm)

    1.4B

  • Net Income Avi to Common (ttm)

    -44.67M

  • Diluted EPS (ttm)

    -2.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    250.85M

  • Total Debt/Equity (mrq)

    41.76%

  • Levered Free Cash Flow (ttm)

    -24.66M

Research Analysis: 0RJT.IL

View More

Company Insights: 0RJT.IL

Research Reports: 0RJT.IL

View More

People Also Watch